Receptor and channel heteromers as pain targets

Kelly A. Berg, Amol M Patwardhan, Armen N. Akopian

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recent discoveries indicate that many G-protein coupled receptors (GPCRs) and channels involved in pain modulation are able to form receptor heteromers. Receptor and channel heteromers often display distinct signaling characteristics, pharmacological properties and physiological function in comparison to monomer/homomer receptor or ion channel counterparts. It may be possible to capitalize on such unique properties to augment therapeutic efficacy while minimizing side effects. For example, drugs specifically targeting heteromers may have greater tissue specificity and analgesic efficacy. This review will focus on current progress in our understanding of roles of heteromeric GPCRs and channels in pain pathways as well as strategies for controlling pain pathways via targeting heteromeric receptors and channels. This approach may be instrumental in the discovery of novel classes of drugs and expand our repertoire of targets for pain pharmacotherapy.

Original languageEnglish (US)
Pages (from-to)249-278
Number of pages30
JournalPharmaceuticals
Volume5
Issue number3
DOIs
StatePublished - 2012

Fingerprint

Pain
G-Protein-Coupled Receptors
Organ Specificity
Drug Delivery Systems
Ion Channels
Analgesics
Pharmacology
Drug Therapy
Pharmaceutical Preparations
Therapeutics

Keywords

  • Channels
  • Heteromers
  • Pain
  • Receptors
  • Sensory neurons

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Receptor and channel heteromers as pain targets. / Berg, Kelly A.; Patwardhan, Amol M; Akopian, Armen N.

In: Pharmaceuticals, Vol. 5, No. 3, 2012, p. 249-278.

Research output: Contribution to journalArticle

Berg, Kelly A. ; Patwardhan, Amol M ; Akopian, Armen N. / Receptor and channel heteromers as pain targets. In: Pharmaceuticals. 2012 ; Vol. 5, No. 3. pp. 249-278.
@article{c87a70ae9ff14e4087f2d565b1468c63,
title = "Receptor and channel heteromers as pain targets",
abstract = "Recent discoveries indicate that many G-protein coupled receptors (GPCRs) and channels involved in pain modulation are able to form receptor heteromers. Receptor and channel heteromers often display distinct signaling characteristics, pharmacological properties and physiological function in comparison to monomer/homomer receptor or ion channel counterparts. It may be possible to capitalize on such unique properties to augment therapeutic efficacy while minimizing side effects. For example, drugs specifically targeting heteromers may have greater tissue specificity and analgesic efficacy. This review will focus on current progress in our understanding of roles of heteromeric GPCRs and channels in pain pathways as well as strategies for controlling pain pathways via targeting heteromeric receptors and channels. This approach may be instrumental in the discovery of novel classes of drugs and expand our repertoire of targets for pain pharmacotherapy.",
keywords = "Channels, Heteromers, Pain, Receptors, Sensory neurons",
author = "Berg, {Kelly A.} and Patwardhan, {Amol M} and Akopian, {Armen N.}",
year = "2012",
doi = "10.3390/ph5030249",
language = "English (US)",
volume = "5",
pages = "249--278",
journal = "Pharmaceuticals",
issn = "1424-8247",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "3",

}

TY - JOUR

T1 - Receptor and channel heteromers as pain targets

AU - Berg, Kelly A.

AU - Patwardhan, Amol M

AU - Akopian, Armen N.

PY - 2012

Y1 - 2012

N2 - Recent discoveries indicate that many G-protein coupled receptors (GPCRs) and channels involved in pain modulation are able to form receptor heteromers. Receptor and channel heteromers often display distinct signaling characteristics, pharmacological properties and physiological function in comparison to monomer/homomer receptor or ion channel counterparts. It may be possible to capitalize on such unique properties to augment therapeutic efficacy while minimizing side effects. For example, drugs specifically targeting heteromers may have greater tissue specificity and analgesic efficacy. This review will focus on current progress in our understanding of roles of heteromeric GPCRs and channels in pain pathways as well as strategies for controlling pain pathways via targeting heteromeric receptors and channels. This approach may be instrumental in the discovery of novel classes of drugs and expand our repertoire of targets for pain pharmacotherapy.

AB - Recent discoveries indicate that many G-protein coupled receptors (GPCRs) and channels involved in pain modulation are able to form receptor heteromers. Receptor and channel heteromers often display distinct signaling characteristics, pharmacological properties and physiological function in comparison to monomer/homomer receptor or ion channel counterparts. It may be possible to capitalize on such unique properties to augment therapeutic efficacy while minimizing side effects. For example, drugs specifically targeting heteromers may have greater tissue specificity and analgesic efficacy. This review will focus on current progress in our understanding of roles of heteromeric GPCRs and channels in pain pathways as well as strategies for controlling pain pathways via targeting heteromeric receptors and channels. This approach may be instrumental in the discovery of novel classes of drugs and expand our repertoire of targets for pain pharmacotherapy.

KW - Channels

KW - Heteromers

KW - Pain

KW - Receptors

KW - Sensory neurons

UR - http://www.scopus.com/inward/record.url?scp=84858858915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858858915&partnerID=8YFLogxK

U2 - 10.3390/ph5030249

DO - 10.3390/ph5030249

M3 - Article

AN - SCOPUS:84858858915

VL - 5

SP - 249

EP - 278

JO - Pharmaceuticals

JF - Pharmaceuticals

SN - 1424-8247

IS - 3

ER -